Morning Overview on MSN
New bio-implant could finally repair broken spinal cords
A series of converging advances in bio-implant technology, from brain-spine interfaces to lab-grown spinal tissue, is ...
SEONGNAM, South Korea, April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative ...
SANTA FE, N.M., Oct. 1, 2025 /PRNewswire/ -- Mercury Bio (www.mercurybio.com), a drug delivery company leveraging its novel and proprietary extracellular vesicle (EV) drug encapsulation platform (yEV™ ...
Highlight brain imaging analysis solutions, including 'Neurophet AQUA AD', which monitors side effects from Alzheimer's disease treatments To accelerate partnering efforts with global pharmaceutical ...
JuneBrain Inc., a Baltimore-based neurotech startup, took first place at the 2025 BioChallenge Pitch Competition, held October 30 at the New Orleans BioInnovation Center (NOBIC). The annual contest ...
BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to commence in Q4 2025 SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical ...
Manifold Biotechnologies Inc. has signed a strategic research collaboration and license agreement with F. Hoffmann-La Roche Ltd. to develop next-generation brain shuttles for neurological diseases.
A bio-inspired adhesive patch puts some mussel into treating glioblastoma – the most aggressive brain tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results